Better clinical screening and updated provider training foster open communication to identify cannabis-related health risks ...

BDX looks undervalued at 12–13x P/E with 7–8% growth, a 2.78% dividend, buybacks, and debt reduction. Click for more on BDX stock.

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global ...

ELS, REXR, EPRT, VICI & AMT—discounted valuations, strong balance sheets, and return targets. Click here to read more.